The High Prevalence of the Virus Will Drive Herpes Simplex Virus Treatment Market to US$ 2.68 Billion by 2031, Says Growth Plus Reports

Newark, New Castle, USA, March 30, 2023 (GLOBE NEWSWIRE) — The recent report from Growth Plus Reports analyzes the manufacturing strategies, applications, demand, competitors, and SWOT analysis of the global herpes simplex virus treatment market.

The herpes simplex virus treatment market report assists in the optimum deciding the best distribution methods for certain products and markets for new product launches. You can get insights into valuable data, information, statistics, trends, and competitive landscape through the report’s comprehensive TOC, Tables, and charts.

Key Takeaways:

• The increasing prevalence of herpes simplex will drive market revenue growth.
• Increased public awareness regarding the symptoms, transmission, and treatment options will drive demand for herpes simplex virus treatment.
• North America dominates the global herpes simplex virus treatment market. 

Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/herpes-simplex-virus-treatment-market/8469

                              Herpes Simplex Virus Treatment Market Scope

Market Drivers
The high prevalence of the herpes simplex virus, increased awareness among people, and advancements in diagnostic and treatment technologies will drive the revenue growth of the herpes simplex virus treatment market. Furthermore, the development of sensitive and specific diagnostic tests for early diagnosis, growing healthcare expenditures, and increased demand for high-quality healthcare services are expected to boost the market revenue growth rate. Rising emphasis on developing novel HSV therapeutics, vaccinations, and multiple potential drugs and vaccines in clinical trials is expected to support the market’s revenue growth.

Market Segmentation
Growth Plus Reports has analyzed the global herpes simplex virus treatment market from four perspectives: Type, Drug Type, Route of Administration, and Region.

Type Segmentation: Based on the type, the herpes simplex virus treatment market is segmented into Herpes Simplex Virus-1 (HSV-1) and Herpes Simplex Virus-2 (HSV-2). The Herpes Simplex Virus-1 (HSV-1) segment accounts for the largest revenue share because of the high risk of HSV-1 transmission, which can occur through oral-genital contact, contact with contaminated saliva, ulcers, or even skin sores.

Drug Type Segmentation: Based on the drug type, the global herpes simplex virus treatment market is segmented into Famciclovir, Acyclovir, Valacyclovir, and Others. The Acyclovir segment dominates the market because it is regarded as the most effective medication for treating herpes infections.

Route of Administration Segmentation: Based on the route of administration, the herpes simplex virus treatment market is segmented into topical, injectable, and oral. The oral segment dominates the market because of its efficiency, simplicity, quick action, and high adoption.

Regional Growth Dynamics
Based on the region, the global herpes simplex virus treatment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America dominates the herpes simplex virus treatment market with the largest revenue share. The growing usage of branded herpes medications, rising healthcare expenditure, the availability of generic medications, and favorable reimbursement policies in this region are attributed to North America’s large revenue share in the global market.  

Request for Customization – https://www.growthplusreports.com/inquiry/customization/herpes-simplex-virus-treatment-market/8469

Competitive Landscape
The major players operating in the global herpes simplex virus treatment market are:
· Viatris Inc.
· Teva Pharmaceuticals Industries Ltd.
· Sanofi SA
· Novartis AG
· Emcure Pharmaceuticals Ltd.
· GlaxoSmithKline Plc
· Carlsbad Tech
· Fresenius Kabi AG
· Apotex Inc.
· Fresenius SE & Co. KGaA
· Agenus Inc.
· Merck & Co. Inc.
· Avet Pharmaceuticals Inc.

The herpes simplex virus treatment devices market is moderately competitive, with several international players involved. Market players focus on technological advancements, R&D, mergers, and acquisitions to strengthen their market presence.

Recent developments:

• Vaccines AB and Redbiotec AG signed a research and collaboration agreement in June 2022 to diversify their offering and study the HSV-2 vaccine.

• United BioPharma will collaborate with the Shanghai Public Health Clinical Centre and the Department of Microbiology and Immunology at Cheng Kung University in October 2021 to investigate the efficacy of UB-621, a best-in-class long-acting medication for genital herpes caused by simplex viruses 1 and 2. (HSV 1 and HSV2).

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL HERPES SIMPLEX VIRUS TREATMENT MARKET – ANALYSIS & FORECAST, BY TYPE
   1. Herpes Simplex Virus-1 (HSV-1)
   2. Herpes Simplex Virus-2 (HSV-2)
6. GLOBAL HERPES SIMPLEX VIRUS TREATMENT MARKET – ANALYSIS & FORECAST, BY DRUG TYPE
   1. Famciclovir
   2. Acyclovir
   3. Valacyclovir
   4. Others
7. GLOBAL HERPES SIMPLEX VIRUS TREATMENT MARKET – ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
   1. Topical
   2. Injectable
   3. Oral

HERPES SIMPLEX VIRUS TREATMENT MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8469

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse related reports:

Transfusion Technology Market by Product (Instruments, Disposables & Consumables), Application (Blood Screening, Blood Group Typing), End User (Hospital Based Laboratories, Independent Laboratories & Blood Banks) – Global Outlook & Forecast 2023-2031

Transcatheter Heart Valve Replacement Market by Product (Transcatheter Aortic Valve Replacement (TAVR)), Indication (Severe Aortic Valve Stenosis), Procedure (Transaortic), End user (Hospitals, Ambulatory Surgical Centers) – Global Outlook & Forecast 2022-2030

Surgical Apparel Market by Type (Disposable and Reusable), Product (Scrubs, Gowns, Caps, Gloves, Mask, and Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others) – Global Outlook & Forecast 2023-2031

Pulse Electromagnetic Field Therapy Devices Market by Power (Low Frequency, High Frequency), Application (Pain Management, Bone Growth), End User (Hospitals, Home Care Settings) – Global Outlook & Forecast 2023-2031

Multiplex Biomarker Imaging Market by Component Type (Instruments, Software), Imaging Techniques (Immunohistochemistry, Fluorescent In-situ Hybridization), Application (Research, Clinical Diagnostics), End User (Translational Laboratory, Biopharmaceuticals) – Global Outlook & Forecast 2023-2031

Livestock Monitoring Market by Animal Type (Cattle, Poultry), Component (Hardware, Software), Application (Milk Harvesting, Feeding Management) – Global Outlook & Forecast 2023-2031

Laser-Induced Breakdown Spectroscopy Market by Product Type (Desktop, Handheld), End User (Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes)-Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.